
|
 |

J Clin Outcomes Manage
2006 Dec;13(12):707-714
Treatment of generalized anxiety disorder Berrettini W
Educational Needs Addressed Generalized anxiety disorder (GAD) is a common disorder with a lifetime prevalence of about 5% in the United States. Its course tends to be chronic and recurrent. GAD is associated with significant impairment, including loss of productivity and reduced quality of life. As patients often present to their primary care physician, optimal recognition and appropriate therapy are critical skills in the primary care setting. The costs of GAD to society may be avoidable with more widespread awareness, recognition, and appropriate intervention. Educational Objectives After participating in this CME activity, primary care physicians should be able to 1. Describe the epidemiology of GAD 2. Identify pharmacologic and nonpharmacologic agents used in the treatment of GAD 3. Discuss treatment regimens that may be employed to attain symptom remission
Case-Based Review, CME
Search the Turner White index to find abstracts of articles published in JCOM.
|